In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.
More From The Market Online
ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024
The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
- Sean Boss
- 2 mins
- 22 November 2024 17:25 (AEDT)
HotCopper Highlights: Your most watched stocks for Week 47, 2024
In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
- Jonathon Davidson
- 2 mins
- 22 November 2024 17:25 (AEDT)
Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL
Welcome to the end of another week. Let's start with what HotCopper users have been watching…
- Jonathon Davidson
- 5 mins
- 22 November 2024 16:24 (AEDT)
Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse
The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
- Dale Gillham
- 4 mins
- 22 November 2024 16:20 (AEDT)